Form 4: HealthLynked CEO Michael Dent Acquires Convertible Note and Warrants

HealthLynked Corp's CEO, Michael Dent, through a trust, acquired a convertible note and warrants, signaling potential future equity stake.

Summary

• Michael Dent, CEO, Director, and 10% Owner of HealthLynked Corp, filed a Form 4.
• On June 3, 2024, Dent's trust purchased a 12% convertible note with a face value of $1,000,000 from HealthLynked.
• The conversion price of the note is $0.0497.
• The note is convertible into 20,120,724 shares of common stock, excluding shares issuable upon conversion of accrued interest.
• The trust also received warrants to purchase 10,000,000 shares of HealthLynked's common stock at $0.00 per share as warrant coverage.
• These warrants expire on June 3, 2034.
• Following the transaction, Dent beneficially owns $1,000,000 in convertible notes and 10,000,000 warrants indirectly through the Mary S. Dent Gifting Trust, for which he serves as trustee.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CEO's investment suggests confidence, but the potential dilution is a concern.

Positives

• The CEO's investment in a convertible note may signal confidence in the company's future prospects.
• The warrant coverage provides potential upside for the CEO's trust.

Risks

• The conversion of the note could dilute existing shareholders' equity.
• The exercise of warrants could further dilute existing shareholders' equity.

Industry Context

Insider transactions are closely monitored as they can provide insights into management's perspective on the company's prospects. A purchase of convertible notes and warrants by the CEO could be interpreted as a positive signal.

Stakeholder Impact

• Shareholders may experience dilution if the convertible note is converted and the warrants are exercised.
• The company benefits from the $1,000,000 investment from the CEO's trust.

Key Dates